SlideShare una empresa de Scribd logo
CORNEAL DYSTROPHIES
(CONTINUED…)
Presenter- Dr Harshitha K M
Moderator- Dr Usha B R
LATTICE DYSTROPHY
• TYPES- Type 1- classic, Type 2- Gelsolin
• LCD type I:
– Classic Lattice Corneal Dystrophy/Biber-Haab-
Dimmer
– TGFB1 gene mutation-5q31 gene locus. (AD
inheritance)
– Isolated amyloid deposition in the stroma in a linear
pattern
CLINICAL FEATURES
 Manifests in 1st or 2nd decade with
apparence of thin branching
refractile lines and/or
subepithelial, whitish, ovoid dots.
 The lines start centrally and more
superficially , spreading
centrifugally and deeply but
leaving the periferal 1mm and
Descemet’s membrane
&endothelium clear
Progression
Fine, spidery, branching lines
within stroma.
Later general haze
(ground glass
apparence ) may
submerge lesions.
HISTOPATHOLOGY
 Amyloid stains intensely with Congo Red, shows
birefringence and dichroism.
 Electron miscroscopy shows fine filaments 8 to 10 nm
intermingled with collagenous fibers
 In Vivo confocal microscopy shows linear and branching
structures in the stroma with changing reflectivity and poorly
demarcated margins
TREATMENT
 Recurrent erosions  patching, hypertonic agents,
artificial tears or therapeutic contact lens
 Excimer laser PTK- optional treatment
 If vision is impaired  lamellar /penetrating
keratoplasty
 Recurrence after PK- early ( about 3 years)
LATTICE CORNEAL DEGENERATION- TYPE 2
 Gelsolin type /Finnish type/ familial amyloidosis/
Meretoja syndrome .
 Mutation of gelsolin gene- 9q34.
 Gelsolin is an actin filament modulating protien with
an actin-regulating domain found in leucocytes,
platelets and other cells.
 The amyloid protien in this type of LCD is a
fragment of actin filament binding region of a
variant gelsolin molecule.
CLINICAL FEATURES
 3rd to 4th decade
 Recurrent epithelial erosions
 Vision loss is less compared to other LCD.
 SLE- fewer more periferal lattice lines in corneal
stroma spreading centripetally from the limbus.
 Central cornea is relatively spared .
 Systemic features : Cranial and peripheral
neuropathies- facial paresis, bulbar palsy,
lagophthalmos and autonomic nervous dysfunction.
Lax skin, nephrotic syndrome, renal failure and
cardiomyopathy.
HISTOPATHOLOGY
 Amyloid is deposited in the cornea in lattice lines as a
discontinuous band under the bowmans layer .
 Deposition of gelsolin is also detected in conjunctiva,
sclera, stroma of ciliary body, along chorio capillaries
MACULAR DYSTROPHY
 Slowly progressive
 Autosomal recessive trait
 N acetyl glucosamine 6 sulfotransferase gene
(CHST6 gene) on chromosome 16q 21
 Pathogenesis- ? Incomplete glycosaminoglycan
sulfation
CLINICAL FEATURES
 1st and 3rd decade
 Diffuse stromal haze intially affecting the central cornea,
then extending till the limbus
 Later superficial central elevated irregular whitish
opacities(macules) develop
 NO CLEAR AREAS between the opacities.
 Lesions are more posterior peripheral white lesions.
 The cornea is thinner than normal in early disease and
is probably due to close packing of collagen fibrils.
 In late stages endothelium is affected, guttae+
 Reccurent corneal erosions also +
MACULAR DYSTROPHY
HISTOPATHOLOGY
 GAGs stain with Alcian blue, PAS, metachromatic
dyes and colloidal iron.
 Accumulate intracellularly and extracellularly in the
corneal stroma as well as in the DM.
 The extracellular matrix observed in electron microscopy
contains clumps of fibrogranular material staining positively for
GAGs while keratocytes also stain positive for GAGs.
TREATMENT
 PK is the treatment of choice.
 Reccurences are common
 Perifery of the graft is the most affected as the
keratocytes invade its superficial and deeper layers.
SCHNYDER CORNEAL DYSTROPHY
 Schnyder crystalline corneal dystrophy
 Rare
 1p36 chromosome
Clinical features :
 Presents early in life
 Central discoid opacity just posterior to the bowman’s
membrane, in the anterior stroma.
 Opacity consists of small, needle shaped refractile
crystals with glass wool appearance.
 May be associated with hyperlipoprotienemia
 Vision decreases with age.
CONGENITAL HERIDITARY STROMAL
DYSTROPHY
 Non progressive, heriditary, congenital, bilateral
 Pathogenesis- ? Disordered stromal fibrinogenesis
 12q22
Clinical features:
 @birth, diffuse bilateral corneal clouding with flake like,
whitish opacities, both equally distributed through out the
stroma.
 Epithelium and endothelium are normal
 Stromal thickness is not increased.
 NO signs of vascularization.
 Moderate to severe visual loss, amblyopia and nystagmus
may develop.
 Recurrence after PK is rare
DESCEMET’S MEMBRANE AND ENDOTHELIAL
DYSTROHIES
1. Posterior polymorphous corneal dystrophy
2. congenital heriditary endothelial dystrophy
3. Fuch’s endothelial dystrophy
POSTERIOR POLYMORPHOUS CORNEAL
DYSTROPHY (PPCD)
 Schlichting dystrophy
 Typically non progressive
 VSX1 and COL8A2
Clinical features:
Clinically classified into 3 main forms
Vesicular , band and diffuse.
Vesicles- appear as endothelial blisters or blebs on SLE ,
may be isolated or in clusters or curvilinear patterns
Bands – strips of guttae like irregularities in DM
Diffuse- diffuse irregularities in DM
 Periferal iridocorneal adhesions and rarely
secondary sub epithelial band keratopathy may be
seen
 Glaucoma and keratoconus- associations.
 D/D- ICE syndrome, however sporadic and
unilateral involvement of ICE are distinguishing
factors.
POSTERIOR POLYMORPHOUS DYSTROPHY
HISTOPATHOLOGY
 Descemet’s membrane consists of abnormal anterior band
and an abnormal posterior collagenous layer.
 In the periphery the endothelial cells show metaplasia and
epithelialization with desmosomal attachments, microvilli and
intermediate filaments.
CONGENITAL HERIDITARY ENDOTHELIAL
DYSTROPHY
 Rare cause of congenital corneal edema
 CHED 1(AD) and CHED 2 (AR)
Clinical features:
 Recessive CHED is more common with diffuse corneal
clouding being present at birth
 Nystagmus is often present
 B/l symmetrical, gray blue, ground glass haziness of the
corneal stroma extending to the limbus with no
intervening clear zones.
 Associated marked corneal thickening (2x to 3x)
 Rarely congenital glaucoma may co exist.
HISTOPATHOLOGY
 DM- diffuse thickening and lamination
 Endothelial cells are spare and atrophic
 On electron microscopy- multiple layers of
basement membrane like material can be seen
within posterior collagenous layer of DM.
FUCHS ENDOTHELIAL DYSTROPHY
•1910 Fuch’sgave first clinical description- as the most
common primary disorder of corneal endothelium
• Bilateral ,non inflammatory progressive loss of
endothelium that results in reduction of vision.
Inheritance-
• Most are sporadic
• Occasional AD inheritance
• Mutation in COL8A2 genealso identified
Female preponderance 4: 1
Elderly onset >50 years
SYMPTOMS
• Initially asymptomatic
• Gradual worsening of vision in the
morning, spontaneous improvement
during the day
• Glare
• Halos
• Recurrent foreign body sensation
• Pain due to rupture of bullae
SIGNS Slitlamp
examination-
• Corneal guttata-
irregular warts or
excresences seen in
the DM
• DM folds
• Stromal edema
• Microcystic epithelial
edema
Guttata seen on
PAS stain
Guttata on specular
reflection
–The guttata increase, enlarge
and coalesce and may fuse
with adjacent guttata
disrupting normal
endothelial integrity
known as beaten metal
appearance
• Endothelial decompensation
leading to stromal edema
• Epithelial microcysts
• Bullae
• Bullous keratopathy
COURSE OF DISEASE
• First phase- Asymptomatic with corneal guttata and fine
pigment dusting in the posterior corneal surface,advanced
cases‘beaten metal’.
• Second phase- Corneal edema, Pt experiences glare
and hazy vision. Edema progresses to epithelial
bullae, rupture of these cause severe pain
• Third phase- DM thickening and corneal thickness
upto 1 mm with bullous keratopathy
• Fourth phase- Growth of subepithelial connective tissue ,
decrease in corneal sensations, peripheral
neovascularisation+,
TREATMENT
1. Conservative management with topical Hypertonic
solution sodium chloride 5 % or 6%
2. Reduction of IOP
3. Corneal dehydration with hair dryer
4. Ruptured bullae - Bandage Contact lens ,
cycloplegics, antibiotics and lubricant drops,
Anterior stromal puncture maybe helpful
• When vision is severely affected posterior lamellar
keratoplasty (DSEK,DSAEK,DMEK) can be done
• Full thickness KP when Fuchs has advanced and whole
cornea is affected
• In eyes with poor visual potential conjunctival flap and
amniotic membrane transplantation
• New treatment method of using topical Rho-kinase inhibitor
with prior trans corneal endothelial cryotherapy , stimulates
the endothelial cell proliferation and improve function.
– When associated with cataract- Dilemma arises
whether cataract sx alone can improve vision or
whether cataract sx combined with KP
– The any one of the following indicators if +, combined
procedure should be done- triple procedure of
combined cataract extraction + lens implantation+
keratoplasty
1. The presence of microcystic edema
2. Stromal thickening ( CCT> 640 microns)
3. Low endothelial cell count ( < 1000 cell/mm²)
CORNEAL
GUTTAE
HISTOPATHOLOGY
REC
AP
THANK YOU! 

Más contenido relacionado

La actualidad más candente

Evaluation of ptosis
Evaluation of ptosis Evaluation of ptosis
Evaluation of ptosis
Nikita Jaiswal
 
Fuchs endothelial dystrophy.
Fuchs endothelial dystrophy.Fuchs endothelial dystrophy.
Fuchs endothelial dystrophy.
DiyarAlzubaidy
 
Macular hole
Macular holeMacular hole
Macular hole
Laxmi Eye Institute
 
Primary open angle glaucoma
Primary open angle glaucomaPrimary open angle glaucoma
Primary open angle glaucoma
Sampda Sharma
 
Neuroprotective drugs in glaucoma
Neuroprotective drugs in glaucomaNeuroprotective drugs in glaucoma
Neuroprotective drugs in glaucoma
Nikhil Oza
 
Pathology of cornea 2
Pathology of cornea 2Pathology of cornea 2
Pathology of cornea 2
OPTOM FASLU MUHAMMED
 
Clinical evaluation of optic disc changes
Clinical evaluation of optic disc changesClinical evaluation of optic disc changes
Clinical evaluation of optic disc changes
Dr Saurabh Kushwaha
 
Choroidal neovascularisation(cnv)
Choroidal neovascularisation(cnv)Choroidal neovascularisation(cnv)
Choroidal neovascularisation(cnv)
Nikhil Rp
 
Iol power calculation in pediatric patients
Iol power calculation in pediatric patientsIol power calculation in pediatric patients
Iol power calculation in pediatric patients
Anisha Rathod
 
Age related macular degeneration
Age related macular degenerationAge related macular degeneration
Age related macular degeneration
Nikita Jaiswal
 
Visual Field in Glaucoma
Visual Field in GlaucomaVisual Field in Glaucoma
Visual Field in Glaucoma
docsarsi
 
Available options for keratoconus management
Available options for keratoconus managementAvailable options for keratoconus management
Available options for keratoconus management
Amr Mounir
 
Keratoconus...
Keratoconus...Keratoconus...
Keratoconus...
Reema Dandavate
 
Keratoconus
KeratoconusKeratoconus
Keratoconus
drkvasantha
 
Orbital inflammatory disease
Orbital inflammatory diseaseOrbital inflammatory disease
Orbital inflammatory disease
NeurologyKota
 
Pseudo-Ophthalmology !
Pseudo-Ophthalmology !Pseudo-Ophthalmology !
Pseudo-Ophthalmology !
Ahmed Alsherbeny
 
Branch Retinal Vein Occlusion
Branch Retinal Vein Occlusion Branch Retinal Vein Occlusion
Branch Retinal Vein Occlusion
Kh.Towkir-Ul- Islam
 
Pentacam analysis
Pentacam analysisPentacam analysis
Pentacam analysis
Nikhil Rp
 
Primary open angle glaucoma(POAG)
Primary open angle glaucoma(POAG)Primary open angle glaucoma(POAG)
Primary open angle glaucoma(POAG)
rakshyabasnet1
 
Amniotic membrane transplantation
Amniotic membrane transplantation Amniotic membrane transplantation
Amniotic membrane transplantation
mohammed irshad
 

La actualidad más candente (20)

Evaluation of ptosis
Evaluation of ptosis Evaluation of ptosis
Evaluation of ptosis
 
Fuchs endothelial dystrophy.
Fuchs endothelial dystrophy.Fuchs endothelial dystrophy.
Fuchs endothelial dystrophy.
 
Macular hole
Macular holeMacular hole
Macular hole
 
Primary open angle glaucoma
Primary open angle glaucomaPrimary open angle glaucoma
Primary open angle glaucoma
 
Neuroprotective drugs in glaucoma
Neuroprotective drugs in glaucomaNeuroprotective drugs in glaucoma
Neuroprotective drugs in glaucoma
 
Pathology of cornea 2
Pathology of cornea 2Pathology of cornea 2
Pathology of cornea 2
 
Clinical evaluation of optic disc changes
Clinical evaluation of optic disc changesClinical evaluation of optic disc changes
Clinical evaluation of optic disc changes
 
Choroidal neovascularisation(cnv)
Choroidal neovascularisation(cnv)Choroidal neovascularisation(cnv)
Choroidal neovascularisation(cnv)
 
Iol power calculation in pediatric patients
Iol power calculation in pediatric patientsIol power calculation in pediatric patients
Iol power calculation in pediatric patients
 
Age related macular degeneration
Age related macular degenerationAge related macular degeneration
Age related macular degeneration
 
Visual Field in Glaucoma
Visual Field in GlaucomaVisual Field in Glaucoma
Visual Field in Glaucoma
 
Available options for keratoconus management
Available options for keratoconus managementAvailable options for keratoconus management
Available options for keratoconus management
 
Keratoconus...
Keratoconus...Keratoconus...
Keratoconus...
 
Keratoconus
KeratoconusKeratoconus
Keratoconus
 
Orbital inflammatory disease
Orbital inflammatory diseaseOrbital inflammatory disease
Orbital inflammatory disease
 
Pseudo-Ophthalmology !
Pseudo-Ophthalmology !Pseudo-Ophthalmology !
Pseudo-Ophthalmology !
 
Branch Retinal Vein Occlusion
Branch Retinal Vein Occlusion Branch Retinal Vein Occlusion
Branch Retinal Vein Occlusion
 
Pentacam analysis
Pentacam analysisPentacam analysis
Pentacam analysis
 
Primary open angle glaucoma(POAG)
Primary open angle glaucoma(POAG)Primary open angle glaucoma(POAG)
Primary open angle glaucoma(POAG)
 
Amniotic membrane transplantation
Amniotic membrane transplantation Amniotic membrane transplantation
Amniotic membrane transplantation
 

Similar a Stromal and endothelial dystrophies ppt

CORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVE
CORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVECORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVE
CORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVE
ANUJA DHAKAL
 
Corneal dystrophy by_dr.adnan
Corneal dystrophy by_dr.adnanCorneal dystrophy by_dr.adnan
Corneal dystrophy by_dr.adnan
MahamudAdnan
 
CORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptx
CORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptxCORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptx
CORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptx
DHIR EYE HOSPITAL
 
Corneal dystrophies
Corneal dystrophiesCorneal dystrophies
Corneal dystrophies
Najara Thapa
 
Corneal dystrophies
Corneal dystrophiesCorneal dystrophies
Corneal dystrophies
Nikita Jaiswal
 
Corneal dystrophy
Corneal dystrophyCorneal dystrophy
Corneal dystrophy
Harsha Prathapasinghe
 
corneal dystrophy.pptx
corneal dystrophy.pptxcorneal dystrophy.pptx
corneal dystrophy.pptx
RashtriyaSamajseviPa
 
Corneal dystrophies
Corneal dystrophies Corneal dystrophies
Corneal dystrophies
jyotigontia
 
CORNEAL DYSTROPHIES AND ECTASIAS.pptx
CORNEAL DYSTROPHIES  AND ECTASIAS.pptxCORNEAL DYSTROPHIES  AND ECTASIAS.pptx
CORNEAL DYSTROPHIES AND ECTASIAS.pptx
Iddi Ndyabawe
 
cornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdf
cornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdfcornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdf
cornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdf
Vinodhini92
 
Corneal Dystrophies
Corneal DystrophiesCorneal Dystrophies
Corneal Dystrophies
Puneet Sharma
 
CORNEAL DYSTROPHIES
CORNEAL DYSTROPHIESCORNEAL DYSTROPHIES
CORNEAL DYSTROPHIES
Dr. Jaya Malviya
 
CORNEAL DYSTROPHY and degen.pptx
CORNEAL DYSTROPHY and degen.pptxCORNEAL DYSTROPHY and degen.pptx
CORNEAL DYSTROPHY and degen.pptx
ManoAarthi1
 
Presentation on CORNEAL DYSTROPHY PPT.pptx
Presentation on CORNEAL DYSTROPHY PPT.pptxPresentation on CORNEAL DYSTROPHY PPT.pptx
Presentation on CORNEAL DYSTROPHY PPT.pptx
drnisha008
 
Corneal dystrophies
Corneal dystrophiesCorneal dystrophies
Corneal dystrophies
drkvasantha
 
Parth cd
Parth cdParth cd
Parth cd
Parth Vora
 
Sailing through cornea part 2
Sailing through cornea  part 2Sailing through cornea  part 2
Sailing through cornea part 2
Samhaa Mohammed
 
RETINA-retinal detatchment powerpoint presentation
RETINA-retinal detatchment powerpoint presentationRETINA-retinal detatchment powerpoint presentation
RETINA-retinal detatchment powerpoint presentation
SandeepKrishnan42
 
Non ulcerative keratitis
Non ulcerative keratitisNon ulcerative keratitis
Non ulcerative keratitis
OPTOM FASLU MUHAMMED
 
Corneal degenerations
Corneal degenerationsCorneal degenerations
Corneal degenerations
drkvasantha
 

Similar a Stromal and endothelial dystrophies ppt (20)

CORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVE
CORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVECORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVE
CORNEAL DYSTROPHIES PRESENTATION IN OPTOMETRIST PERSPECTIVE
 
Corneal dystrophy by_dr.adnan
Corneal dystrophy by_dr.adnanCorneal dystrophy by_dr.adnan
Corneal dystrophy by_dr.adnan
 
CORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptx
CORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptxCORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptx
CORNEAL_DYSTROPHIES_Autosaved_DHBbwn.pptx
 
Corneal dystrophies
Corneal dystrophiesCorneal dystrophies
Corneal dystrophies
 
Corneal dystrophies
Corneal dystrophiesCorneal dystrophies
Corneal dystrophies
 
Corneal dystrophy
Corneal dystrophyCorneal dystrophy
Corneal dystrophy
 
corneal dystrophy.pptx
corneal dystrophy.pptxcorneal dystrophy.pptx
corneal dystrophy.pptx
 
Corneal dystrophies
Corneal dystrophies Corneal dystrophies
Corneal dystrophies
 
CORNEAL DYSTROPHIES AND ECTASIAS.pptx
CORNEAL DYSTROPHIES  AND ECTASIAS.pptxCORNEAL DYSTROPHIES  AND ECTASIAS.pptx
CORNEAL DYSTROPHIES AND ECTASIAS.pptx
 
cornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdf
cornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdfcornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdf
cornealdystrophies-150324080331-conversion-gate01 (1)_copy_signed.pdf
 
Corneal Dystrophies
Corneal DystrophiesCorneal Dystrophies
Corneal Dystrophies
 
CORNEAL DYSTROPHIES
CORNEAL DYSTROPHIESCORNEAL DYSTROPHIES
CORNEAL DYSTROPHIES
 
CORNEAL DYSTROPHY and degen.pptx
CORNEAL DYSTROPHY and degen.pptxCORNEAL DYSTROPHY and degen.pptx
CORNEAL DYSTROPHY and degen.pptx
 
Presentation on CORNEAL DYSTROPHY PPT.pptx
Presentation on CORNEAL DYSTROPHY PPT.pptxPresentation on CORNEAL DYSTROPHY PPT.pptx
Presentation on CORNEAL DYSTROPHY PPT.pptx
 
Corneal dystrophies
Corneal dystrophiesCorneal dystrophies
Corneal dystrophies
 
Parth cd
Parth cdParth cd
Parth cd
 
Sailing through cornea part 2
Sailing through cornea  part 2Sailing through cornea  part 2
Sailing through cornea part 2
 
RETINA-retinal detatchment powerpoint presentation
RETINA-retinal detatchment powerpoint presentationRETINA-retinal detatchment powerpoint presentation
RETINA-retinal detatchment powerpoint presentation
 
Non ulcerative keratitis
Non ulcerative keratitisNon ulcerative keratitis
Non ulcerative keratitis
 
Corneal degenerations
Corneal degenerationsCorneal degenerations
Corneal degenerations
 

Último

Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
Gokuldas Hospital
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
FFragrant
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
FFragrant
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
suvadeepdas911
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
AyushGadhvi1
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
phuakl
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 

Último (20)

Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
What are the different types of Dental implants.
What are the different types of Dental implants.What are the different types of Dental implants.
What are the different types of Dental implants.
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptxPost-Menstrual Smell- When to Suspect Vaginitis.pptx
Post-Menstrual Smell- When to Suspect Vaginitis.pptx
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
 
CBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdfCBL Seminar 2024_Preliminary Program.pdf
CBL Seminar 2024_Preliminary Program.pdf
 
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Ageing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public HealthAgeing, the Elderly, Gerontology and Public Health
Ageing, the Elderly, Gerontology and Public Health
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 

Stromal and endothelial dystrophies ppt

  • 1. CORNEAL DYSTROPHIES (CONTINUED…) Presenter- Dr Harshitha K M Moderator- Dr Usha B R
  • 2. LATTICE DYSTROPHY • TYPES- Type 1- classic, Type 2- Gelsolin • LCD type I: – Classic Lattice Corneal Dystrophy/Biber-Haab- Dimmer – TGFB1 gene mutation-5q31 gene locus. (AD inheritance) – Isolated amyloid deposition in the stroma in a linear pattern
  • 3. CLINICAL FEATURES  Manifests in 1st or 2nd decade with apparence of thin branching refractile lines and/or subepithelial, whitish, ovoid dots.  The lines start centrally and more superficially , spreading centrifugally and deeply but leaving the periferal 1mm and Descemet’s membrane &endothelium clear
  • 4. Progression Fine, spidery, branching lines within stroma. Later general haze (ground glass apparence ) may submerge lesions.
  • 5. HISTOPATHOLOGY  Amyloid stains intensely with Congo Red, shows birefringence and dichroism.
  • 6.  Electron miscroscopy shows fine filaments 8 to 10 nm intermingled with collagenous fibers  In Vivo confocal microscopy shows linear and branching structures in the stroma with changing reflectivity and poorly demarcated margins
  • 7.
  • 8. TREATMENT  Recurrent erosions  patching, hypertonic agents, artificial tears or therapeutic contact lens  Excimer laser PTK- optional treatment  If vision is impaired  lamellar /penetrating keratoplasty  Recurrence after PK- early ( about 3 years)
  • 9. LATTICE CORNEAL DEGENERATION- TYPE 2  Gelsolin type /Finnish type/ familial amyloidosis/ Meretoja syndrome .  Mutation of gelsolin gene- 9q34.  Gelsolin is an actin filament modulating protien with an actin-regulating domain found in leucocytes, platelets and other cells.  The amyloid protien in this type of LCD is a fragment of actin filament binding region of a variant gelsolin molecule.
  • 10. CLINICAL FEATURES  3rd to 4th decade  Recurrent epithelial erosions  Vision loss is less compared to other LCD.  SLE- fewer more periferal lattice lines in corneal stroma spreading centripetally from the limbus.  Central cornea is relatively spared .  Systemic features : Cranial and peripheral neuropathies- facial paresis, bulbar palsy, lagophthalmos and autonomic nervous dysfunction. Lax skin, nephrotic syndrome, renal failure and cardiomyopathy.
  • 11. HISTOPATHOLOGY  Amyloid is deposited in the cornea in lattice lines as a discontinuous band under the bowmans layer .  Deposition of gelsolin is also detected in conjunctiva, sclera, stroma of ciliary body, along chorio capillaries
  • 12. MACULAR DYSTROPHY  Slowly progressive  Autosomal recessive trait  N acetyl glucosamine 6 sulfotransferase gene (CHST6 gene) on chromosome 16q 21  Pathogenesis- ? Incomplete glycosaminoglycan sulfation
  • 13. CLINICAL FEATURES  1st and 3rd decade  Diffuse stromal haze intially affecting the central cornea, then extending till the limbus  Later superficial central elevated irregular whitish opacities(macules) develop  NO CLEAR AREAS between the opacities.  Lesions are more posterior peripheral white lesions.  The cornea is thinner than normal in early disease and is probably due to close packing of collagen fibrils.  In late stages endothelium is affected, guttae+  Reccurent corneal erosions also +
  • 15. HISTOPATHOLOGY  GAGs stain with Alcian blue, PAS, metachromatic dyes and colloidal iron.  Accumulate intracellularly and extracellularly in the corneal stroma as well as in the DM.
  • 16.  The extracellular matrix observed in electron microscopy contains clumps of fibrogranular material staining positively for GAGs while keratocytes also stain positive for GAGs.
  • 17. TREATMENT  PK is the treatment of choice.  Reccurences are common  Perifery of the graft is the most affected as the keratocytes invade its superficial and deeper layers.
  • 18. SCHNYDER CORNEAL DYSTROPHY  Schnyder crystalline corneal dystrophy  Rare  1p36 chromosome Clinical features :  Presents early in life  Central discoid opacity just posterior to the bowman’s membrane, in the anterior stroma.  Opacity consists of small, needle shaped refractile crystals with glass wool appearance.  May be associated with hyperlipoprotienemia  Vision decreases with age.
  • 19.
  • 20.
  • 21.
  • 22. CONGENITAL HERIDITARY STROMAL DYSTROPHY  Non progressive, heriditary, congenital, bilateral  Pathogenesis- ? Disordered stromal fibrinogenesis  12q22 Clinical features:  @birth, diffuse bilateral corneal clouding with flake like, whitish opacities, both equally distributed through out the stroma.  Epithelium and endothelium are normal  Stromal thickness is not increased.  NO signs of vascularization.  Moderate to severe visual loss, amblyopia and nystagmus may develop.  Recurrence after PK is rare
  • 23.
  • 24.
  • 25.
  • 26. DESCEMET’S MEMBRANE AND ENDOTHELIAL DYSTROHIES 1. Posterior polymorphous corneal dystrophy 2. congenital heriditary endothelial dystrophy 3. Fuch’s endothelial dystrophy
  • 27. POSTERIOR POLYMORPHOUS CORNEAL DYSTROPHY (PPCD)  Schlichting dystrophy  Typically non progressive  VSX1 and COL8A2 Clinical features: Clinically classified into 3 main forms Vesicular , band and diffuse. Vesicles- appear as endothelial blisters or blebs on SLE , may be isolated or in clusters or curvilinear patterns Bands – strips of guttae like irregularities in DM Diffuse- diffuse irregularities in DM
  • 28.  Periferal iridocorneal adhesions and rarely secondary sub epithelial band keratopathy may be seen  Glaucoma and keratoconus- associations.  D/D- ICE syndrome, however sporadic and unilateral involvement of ICE are distinguishing factors.
  • 30. HISTOPATHOLOGY  Descemet’s membrane consists of abnormal anterior band and an abnormal posterior collagenous layer.  In the periphery the endothelial cells show metaplasia and epithelialization with desmosomal attachments, microvilli and intermediate filaments.
  • 31.
  • 32.
  • 33. CONGENITAL HERIDITARY ENDOTHELIAL DYSTROPHY  Rare cause of congenital corneal edema  CHED 1(AD) and CHED 2 (AR) Clinical features:  Recessive CHED is more common with diffuse corneal clouding being present at birth  Nystagmus is often present  B/l symmetrical, gray blue, ground glass haziness of the corneal stroma extending to the limbus with no intervening clear zones.  Associated marked corneal thickening (2x to 3x)  Rarely congenital glaucoma may co exist.
  • 34.
  • 35. HISTOPATHOLOGY  DM- diffuse thickening and lamination  Endothelial cells are spare and atrophic  On electron microscopy- multiple layers of basement membrane like material can be seen within posterior collagenous layer of DM.
  • 36. FUCHS ENDOTHELIAL DYSTROPHY •1910 Fuch’sgave first clinical description- as the most common primary disorder of corneal endothelium • Bilateral ,non inflammatory progressive loss of endothelium that results in reduction of vision.
  • 37. Inheritance- • Most are sporadic • Occasional AD inheritance • Mutation in COL8A2 genealso identified Female preponderance 4: 1 Elderly onset >50 years
  • 38. SYMPTOMS • Initially asymptomatic • Gradual worsening of vision in the morning, spontaneous improvement during the day • Glare • Halos • Recurrent foreign body sensation • Pain due to rupture of bullae
  • 39. SIGNS Slitlamp examination- • Corneal guttata- irregular warts or excresences seen in the DM • DM folds • Stromal edema • Microcystic epithelial edema
  • 40. Guttata seen on PAS stain Guttata on specular reflection
  • 41. –The guttata increase, enlarge and coalesce and may fuse with adjacent guttata disrupting normal endothelial integrity known as beaten metal appearance
  • 42. • Endothelial decompensation leading to stromal edema • Epithelial microcysts • Bullae • Bullous keratopathy
  • 43. COURSE OF DISEASE • First phase- Asymptomatic with corneal guttata and fine pigment dusting in the posterior corneal surface,advanced cases‘beaten metal’. • Second phase- Corneal edema, Pt experiences glare and hazy vision. Edema progresses to epithelial bullae, rupture of these cause severe pain • Third phase- DM thickening and corneal thickness upto 1 mm with bullous keratopathy • Fourth phase- Growth of subepithelial connective tissue , decrease in corneal sensations, peripheral neovascularisation+,
  • 44. TREATMENT 1. Conservative management with topical Hypertonic solution sodium chloride 5 % or 6% 2. Reduction of IOP 3. Corneal dehydration with hair dryer 4. Ruptured bullae - Bandage Contact lens , cycloplegics, antibiotics and lubricant drops, Anterior stromal puncture maybe helpful
  • 45. • When vision is severely affected posterior lamellar keratoplasty (DSEK,DSAEK,DMEK) can be done • Full thickness KP when Fuchs has advanced and whole cornea is affected • In eyes with poor visual potential conjunctival flap and amniotic membrane transplantation • New treatment method of using topical Rho-kinase inhibitor with prior trans corneal endothelial cryotherapy , stimulates the endothelial cell proliferation and improve function.
  • 46. – When associated with cataract- Dilemma arises whether cataract sx alone can improve vision or whether cataract sx combined with KP – The any one of the following indicators if +, combined procedure should be done- triple procedure of combined cataract extraction + lens implantation+ keratoplasty 1. The presence of microcystic edema 2. Stromal thickening ( CCT> 640 microns) 3. Low endothelial cell count ( < 1000 cell/mm²)
  • 48.